VIATRIS Trademark

Trademark Overview

On Monday, November 14, 2022, a trademark application was filed for VIATRIS with the United States Patent and Trademark Office. The USPTO has given the VIATRIS trademark a serial number of 97676560. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2024. This trademark is owned by Mylan Inc.. The VIATRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of ophthalmic conditions
viatris

General Information

Serial Number97676560
Word MarkVIATRIS
Filing DateMonday, November 14, 2022
Status700 - REGISTERED
Status DateTuesday, October 22, 2024
Registration Number7545638
Registration DateTuesday, October 22, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of ophthalmic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 17, 2022
Primary Code005
First Use Anywhere DateThursday, August 1, 2024
First Use In Commerce DateThursday, August 1, 2024

Trademark Owner History

Party NameMylan Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMylan Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMylan Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Thursday, November 17, 2022NEW APPLICATION ENTERED
Thursday, November 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, August 27, 2023ASSIGNED TO EXAMINER
Sunday, August 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024SOU EXTENSION 1 FILED
Tuesday, November 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 29, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, May 29, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, May 29, 2024PETITION TO REVIVE-GRANTED
Wednesday, May 29, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, May 29, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, August 7, 2024SOU EXTENSION 1 GRANTED
Tuesday, August 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024USE AMENDMENT FILED
Monday, September 9, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, September 14, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 22, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

viatris ophthalmic conditions treatment human preparations pharmaceutical